Stock Market & Financial News
Dogecoin Price Risks Deeper Drop as DOGE Loses Key EMA Support
Dogecoin is facing renewed downside pressure after failing to sustain its strong August recovery, with DOGE slipping below a key technical support level that could determine its next major price move. DOGE is trading around $0.0808, slightly below the 100-day exponential moving average (EMA) near $0.0816.
Binance founder CZ eyes $1M Bitcoin as quantum computing threat looms larger
The rapid advancement of quantum computing could necessitate urgent security upgrades in Bitcoin, impacting its future stability and trust. Binance founder CZ eyes $1M Bitcoin as quantum computing threat looms larger.
Gold price will approach $5,000/oz in 2026, $5,300/oz in 2027 on ‘uncertainty, de-dollarization, and debasement concern' – RBC
Gold's recent price action has demonstrated that geopolitical instability, global de-dollarization and worries over U.S. dollar debasement are returning to the fore, and the yellow metal is now poised to resume its march above $5,000 per ounce, according to Christopher Louney, Director of Global Commodity Strategy and MENA Research at RBC Capital Markets.
AAAU Magnite Rallies 6%, Trade Desk Climbs 5%, AppLovin Barely Budges: Is Agentic Ad-Tech Broadening Out?
Two programmatic advertising names are running higher by midday Wednesday while the broader technology index barely moves, an unusual split for a corner of the market that usually trades as one basket.
MGNI 
Dell's $95 Billion Backlog Answers the AI Question
The AI backlog alone now represents roughly 84% of last year's total company revenue.
DELL 
NVT Trades at Premium Valuation: Buy, Sell or Hold the Stock?
nVent Electric's strong data center and power utility demand, rising earnings estimates and capacity expansion support the case to buy despite its premium valuation.
NVT 
South Korea ETFs: A Short-Term Pullback, a Long-Term Opportunity
South Korea ETFs are pulling back, but robust exports and rising AI spending could create a compelling long-term buying opportunity.
AIA 
USD/JPY outlook: Hawkish BoJ and speculation of another intervention were likely behind today's sharp fall
USD/JPY outlook: Hawkish BoJ and speculation of another intervention were likely behind today's sharp fall
XRP Price Slides 27% in 2026 as XRPL Stablecoins, Tokenization Surge
XRP fell sharply in the first eight months of 2026, but activity across the XRP Ledger moved in the opposite direction. Stablecoins, tokenized assets, and Ripple's institutional infrastructure all expanded, creating a widening gap between the XRP price and underlying network development.
Filecoin (FIL) Jumps 15% Daily: Here Are the Next Bullish Targets
"We could be right at the start of this process, right now," a popular X user claimed.
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
GSK to advance its mRNA flu vaccine into phase III after phase II study has shown stronger immune responses and good tolerability.
GSK 
Alpha Box ETF (BOXX) Hits New 52-Week High
For investors seeking momentum, Alpha Architect 1-3 Month Box ETF BOXX is probably on the radar. The fund just hit a 52-week high and has risen 4.06% from its 52-week low price of $113.50/share.
BOXX 
THORChain launches public dashboard tracking revenue and trading metrics
THORChain's transparency initiative could set a new standard for accountability in DeFi, potentially boosting user trust and adoption. THORChain launches public dashboard tracking revenue and trading metrics.
Gold outlook: XAU/USD rebounds but macro and technical pressures persist
We saw a bit of recovery in the stock market since the US open, with the dollar easing lower on suspected BoJ intervention in the USD/JPY helping to calm the nerves. That in turn helped to provide some support for gold, too.
TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript
TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study Transcript
TCRX 
Bitcoin, XRP Flash ‘Bart Simpson' Pattern as Crypto Prices Retreat
Bitcoin and XRP are reviving an old crypto market meme as their recent price action begins to resemble the famous Bart Simpson chart pattern, raising concerns about a potentially sharper cryptocurrency market correction. The formation, named after the spiky-haired character from The Simpsons, describes a rapid price surge followed by sideways trading and an abrupt reversal.
Capital B Raises €7.6M From Adam Back to Expand Bitcoin Treasury
French cryptocurrency treasury firm Capital B (ALCPB) has raised 7.6 million ($8.8 million) from prominent Bitcoin developer and investor Adam Back as it seeks to significantly expand its Bitcoin holdings. The Euronext Growth Paris-listed company issued 13,181,030 new shares to Back at 0.58 per share, with each share accompanied by four warrants, according to a Wednesday filing.
What happened to Costco Next? Customers stunned as access to curated marketplace is abruptly lost
Visitors to Costco Next have been met with confusion and consternation over the past several days after the wholesale giant's curated marketplace for select third-party goods appears to have abruptly shut down without notice. Here's what you need to know.
COST 
Credo Technology Reports Q1 Results: Should Investors Hold or Fold?
CRDO's strong Q1 growth and AI demand face a key test as optical ramps, customer concentration and valuation raise risks.
CRDO 
Should You Buy, Sell or Hold AMAT Stock After a 72.5% YTD Rise?
Applied Materials' AI exposure, broad portfolio and capacity expansion fuel growth, but its premium valuation raises the stakes.
AMAT 
Hershey's Pricing Holds Firm: Can Volume Pressure Ease From Here?
Hershey's pricing drives organic sales growth, but steep volume declines and elasticity remain key tests as the company enters the second half.
HSY 
XLM price struggles, but Stellar's biggest catalyst may still be ahead
Pace is weak now, but the October tokenisation launch could help network the back to its feet.
GitLab's Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
GitLab TodayGTLBGitLab$50.88 +5.79 (+12.84%) As of 12:09 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$18.73▼$55.55Price Target$51.88Add to WatchlistGitLab's NASDAQ: GTLB SaaS-pocalypse rebound is gaining momentum after a software-validating earnings report.
GTLB 
Centrifuge integrates onchain reserve management for loyalty programs with Janus Henderson and SMT
Centrifuge, Janus Henderson, and SMT launch tokenized onchain vaults to manage loyalty program reserves, targeting a $300 billion annual Centrifuge integrates onchain reserve management for loyalty programs with Janus Henderson and SMT.
Solana approves change to token issuance schedule with 67% support
Solana's accelerated disinflation could enhance token scarcity, potentially boosting value, but may impact validator incentives and network dynamics. Solana approves change to token issuance schedule with 67% support.
Should Investors Buy CLS Stock as Earnings Estimates Improve?
Celestica estimates are rising as AI infrastructure demand, new hyperscaler programs and strong cash flow boost Celestica's growth outlook.
CLS 
Bitcoin Slides as Oil Rally Fuels Fed Rate Hike Fears
Bitcoin and the broader cryptocurrency market are facing renewed selling pressure as rising oil prices, a stronger U.S. dollar and expectations for higher interest rates weigh on risk assets. Bitcoin (BTC) traded around $77,277 as crypto markets followed recent weakness in U.S. equities.
ArbitrumDAO reports $6M income in first half of 2026
ArbitrumDAO's robust income and strategic expansion enhance its financial autonomy, positioning it for sustained growth and influence in the blockchain ecosystem. ArbitrumDAO reports $6M income in first half of 2026.
Why Moderna's Cancer Vaccine Matters to Investors
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
MRNA 
Strategy Breaks Two-Month Bitcoin Silence with 4,603 BTC Purchase
Strategy has resumed its Bitcoin accumulation after a roughly two-month pause, purchasing 4,603 BTC for about $369.7 million.
